A cardioprotective agent, JTV519, inhibits apoptotic cell death of postischemic reperfused myocardium through _PKC-mediated ERK activation  by Takenaka, Hiroyuki et al.
m 
E 
312A ABSTRACTS- Myocardial Ischemia and Infarction 
necrosis leading to a cardiomyopathy with feature of hibernation. Early chemokine induc- 
tion and interstitial fibrosis due to frequent sublethal ischemic episodes may have a role 
in mediating left ventricular dysfunction in ischemic cardiomyopathy. 
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836-2 Serum Levels of Unbound Free Fatty Acids Reveal High 
Sens i t iv i ty  for Early Detection of Acute Myocardial 
Infarction in Patient Samples From the TIMI II Trial 
Alan M. Kleinfeld. Kevin J. Kleinfeld, Jesse E. Adams, lIP, TarreyPines Institute for 
Molecular Studies, San Diego, California, Jewish Hospital, Louisville, Kentucky. 
Background: Levels of unbound free fatty acids (FFAu) have been found to increase with 
myocardial cellular ischemia in patients undergoing balloon angioplasty (Kleinfeld et al, 
Am J Cardiol 1996;78:1350). To assess whether FFAu are an effective marker of 
ischemia in acute myocardial infarction (AMI), levels of FFAu were determined in serum 
samples from patients enrolled in the TIMI tl trial (TIMI Study Group, N Engl J Med 
1989;320:618). Methods: Patients in this trial were treated with tissue plasminogen acti- 
vator (topA) for AMI. Blood samples were drawn upon presentation, and then 50 minutes, 
5 h and 8 h after t-PA. These samples have been maintained at -70°C by the National 
Heart Lung Blood Institute. FFAu measurements and partial data analysis has been com- 
pleted on 458 patients (75 F, 383 M). Measurements were done at 22°C using the 
ADIFAB2 (Richieri et al, J Biol Chem 1996;271:11291) fluorescent probe of FFAu 
(healthy controls = 2.6 ± 0.6 nM). Results: FFAu values for the TIMI patients ranged from 
2 to 5000 nM. Average values and standard deviations for each of the 4 blood draws, 
from time of admission to 8 h were: 13 ± 17, 22 ± 25, 11 ± 13, and 10 ± 11 (nM). These 
results indicate, relative to the control population, an approximately 4 fold increase upon 
admission, a further 2 fold increase following t-PA with a gradual decrease within 5 h of t- 
PA. Using a 5 nM cutoff, the predicted sensitivity for detection of AMI was 91% using 
samples at time of admission only, and 98% using time of admission and the 50 minute 
sample. Only 19 % of patients had elevated levels of creatine kinase on admission. 
Specificity was estimated as 93% by comparison with a distribution that includes healthy 
individuals plus patients with non cardiovascular diseases. FFAu values for samples 
drawn at presentation were found to be highly (p<0.025) correlated with mortality; an 
increase of 4 fold in mortality rate is predicted from lowest to highest FFAu levels. Con- 
clusions: These data indicate that levels of FFAu are: 1) a sensitive indicator of ischemia 
in AMI, 2) elevated well before markers of cardiac necrosis, 3) an indictor of reperfusion 
therapy, and 4) a predictor of mortality in these patients. 
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836-3 A Cardioprotective Agent, JTV519, Inhibits Apoptotic 
Cell Death of Postischemic Reperfused Myocardium 
Through _PKC-Medlated ERK Activation 
Hirovuki Takenaka, Yasuki Kihara, Koichi Inagaki, Takeshi Yoneda, Department of 
Cardiovascular Medicine, Kyoto Universi~ Kyoto, Japan. 
Objective: JTV519 (JTV), a 1,4-benzothiazepine derivative, confers cardioprotective 
effects on the post-ischemic, reperfused myocardium through a specific activation of 8-iso- 
form of protein kinase C (PKC) (Inagaki et al., Circulation, 2000). In this study, we further 
tested the hypothesis whether the downstream of ~-PKC activation may link to its inhibitory 
effects on the apoptotic cell death. Methods: Hearts were isolated from male SD rats (n=7, 
for each group), and were coronary-berfused in a Langendodf setup at a constant coronary 
flow under electrical pacing at 3.33Hz. The preparation was treated with lpM JTV or vehi- 
cle for 5 min, and then subjected to a 30-min global ischemia and the subsequent 60-min 
full reperfusion protocol, On the other hand, isolated ventricular myocytes from neonatal 
rats (n--6, for each group) were treated with J'IV or vehicle before an exposure to 50HM 
H202 for 80 rain. Both the heart and cell preparations were subjected to TUNEL staining, 
DNA fragmentation assay, and immunoblotting for phosphorylated forms of JNK, ERK1/2, 
and p38-MAPK. Results: In the reperfused heart preparations, JTV ameliorated the recov- 
ery of left ventdcuJar developed pressure by 80% (p<0,01), which was associated with a 
reduction of TUNEL-positive ventricular myocytes by 10% (p<0.05). in isolated cells, JTV 
reduced the H202-induced TUNEL staining from 43% to 30% (p<0.05). JTV also showed 
substantial decreases of DNA fragmentation in beth preparations. These anti-apoptotic 
effects of JTV were inhibited either by GF109203X (GF, a PKC inhibitor) or by PD98059 
(PD, a MEK inhibitor), In the cell preparations, JTV further increased H202-induced phos- 
phorylation of ERKs by 55% (p<0.01). This ERK activation was decreased by pretreating 
the system with 50~M PD, 5HM GF, and I~M rottlerin(a ~-PKC specific inhibitor) to the lev- 
els of 18.0%, 55.2%, and 31.5%, respectively (p<O,05). JTV did not show significant effects 
on JNK and p38-MAPK phosphorylation. Conclusion: JTV519 protects the post-ischemic 
reperfused myocytes from the apoptotic cell death through a specific activation of the 5- 
PKC/ERK cascade. 
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836-4 Hearts of Stat 6 Knockout Mice Are Resistant to 
Ischemla Reperfusion In jury  
Genbu Yamaura. Shoji Fukoda, Kazuhisa Kishima, Jianhua Cui, Richard M. Engelman, 
Dipak K. Das, University of Connecticut Medical Center, Farmington, Connecticut. 
Background: STATs (Signal transducers and Activators of Transcription) comprise a fam- 
ily of transcription factors that reside in the cytoplasm of resting cells. Recently, isohemia/ 
raperfusion was found to rapidly activate JAK (a group of tyrosine kinases)/STAT signal- 
ing pathway which play a crucial role in myocardial ischemic injury. Specifically, JAK2 
and STAT 6 were activated even after 15 min ischemia and remained activated during 
subsequent repertusion. 
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Methods: To confirm the role of STAT 6 in ischemic injury, we examined if STAT 6 knock- 
out mice devoid of any copies of STAT 6 gene was resistant to ischemio injury. STAT 6 
knockout mice (n=10) and control wild-type mice (n=10) were anesthetized with pento- 
barbital, hearts excized, and perfused via working mode with KI-IB buffer. The working 
mouse hearts were made globally ischemio for 25 min followed by 2 h of repertusion. Left 
ventricular function was monitored at the baseline and during post-ventricular eperfusion 
and infarct size was determined at the end of the reperfusion. 
Results: Heart rates of the STAT 6 knockout (KO) mice were lower compared to wild-type 
(WT) mice at baseline and at 15 min of repeffusion (15R). Knockout mouse hearts dis- 
played significantty better (p<0.05) post-ischemic ventricular recovery as evidence by 
higher left ventricular pressure (LVP) (mm Hg) [BL: 86.5±0.7 (WT) vs. 97.3±1.7 (KO); 
15R: 75.2±1.4 (WT) vs. 82.2±2 (KO); 30R: 71.8±1.4 (wr) vs. 77.8±2.1 (KO)]; higher dp/ 
dtmax (mm Hg/sec) [BL: 4518±76 (WT) vs. 5085±120; 15R:3807±130 (WT) vs. 
4288±134 (KO); 30R: 3529±131 (W-F) vs. 4026±133 (KO). Infarct size determined by 
~'C  staining was lower in STAT 6 KO mouse hearts (41.1±1.6%) compared to those for 
the WT mice (48.6±2.3%). 
Conclusion: The results of this study demonstrate that hearts of STAT 6 knockout mice 
are resistant to ischemia/repedusion injury suggesting a role of STAT 6 gene in the medi- 
ation of cardiac injury. 
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836-5 Glucagon-Like Peptide-1 (GLP-1) L imi ts  Myocardial 
Stunning Following Acute Coronary Occlusion and 
Reperfusion in Conscious Canines 
Lazaros A. Nikolaidis. Teresa Hentosz, Aaron Doverspike, Rhonda Huerbin, Lee 
ZoureUas, Carol Stalarski, Dariush Elahi, Richard P. Shannon, AI/egheny Genera/ 
Hoapita/, Pittsburgh, Pennsy/vania, Massachusetts Genera/Hoapita/, Boston, 
Massachusetts. 
Background: Myocardial ischemia is associated with increased glucose utilization. Glu- 
cose insulin K+ infusion has been shown to improve outcomes. We hypothesized that 
the insulinotropio peptide GLP-1 facilitates recovery of post-ischemic contractile dysfunc- 
tion (stunning). 
Methods: We studied 13 conscious dogs, instrumented with LV pressure gauges, aortic 
and coronary flow (CBF) probes, piezoelectric crystats to measure regional systolic wall 
thickening (W'rh) and a hydraulic coronary artery occluder. All dogs underwent a 10 min 
coronary occlusion (CAO) followed by reperfusion (CAR). Five dogs received a 24-hr 
infusion of GLP-1 (1.5 pmolokg'l-min "1) initiated 1 rain prior to CAR; 8 dogs received pla- 
cebo. We obtained serial recordings tar the first 3 hrs and at 24-hr post-CAR, 
Reaults: Hemodynamic responses and global LV function during CAO and CAR were 
similar in the two groups. Baseline regional W'rh (2.6+_0.3mm) and initial hyperemio 
responses were similar. Despite comparable changes in CBF, GLP-1 treated dogs dem- 
onstrated significantly (*p<0.01) ~ess post-ischemic contractile dysfunction. The salutary 
effects of GLP-1 were sustained for 24-hrs. 
Regional CBF (ml )  Regional WTh (% baseline) 
Control GLP-1 Control GLP-1 
Baseline 21+_1 20+_2 100% 100% 
CAO 3+~ 5+~2 12+8% 16_+11% 
CAR-1 min 113+-9 93+11 76_+6% 84+8% 
5 min 49_+8 41_+9 60+-4% 81_+4%* 
10 rain 22_+2 18_+2 57_+5% 84_+2%* 
15 rain 18_+1 17:~2. 57+5% 87_+2%* 
30 min 19_+2 19.+..2 60+-6% 86_+3%* 
1 hr 17_+1 18_+3 69+-5% 97_+3% ° 
2 hr 17_+2 18:1:2 70-+5% 97_+3%* 
3 hr 17+~ 17_+3 76_+6% 98_+2%* 
24 hr 22.+.2 22~_1 78_+4% 98_+4%* 
Conclusions: When administered at the time of repedusion, GLP-1 limits myocardial 
stunning following brief coronary occlusion. The salutary outcome is sustained for at 
least 24 hrs. GLP-1 may be a promising adjuvant herapy in post-ischemic myocardial 
dysfunction. 
5:15 p.m. 
836-6 Cardiac Serum Marker Release After Percutaneous 
Transluminal Septal Myocardial Ablation: A Human 
Model 
Patricia A. Gum, Steven R. SteinhubL Harry M. Lever, E Van Lente, E. Murat Tuzcu, A. 
Michael Lincoff, The C/eve/and Clinic Foundation, C/eve/and, Ohio. 
Background. Multiple cardiac serum markers are available for determining myocardial cell 
death, but the comparative kinetics of these markers in humans have not yet been fully 
described due to the inability to precisely correlate symptom onset with vessel closure. Per- 
cutaneous transluminal septal myocardial ablation (PTMSA) for hypertrophic obstructive 
cardiomyopathy permits a unique opportunity to identify the time of vessel closure in a 
series Of patients experiencing a MI and compare the course of cardiac serum marker eleo 
vation. 
Methods. We obtained bleed samples every 2 hrs for 48 hrs from t l  pts after PTMSA and 
measured the serum markers: creatine kinase MB (CK MB)(normal 0.0-8.8 ng/ml), myoglo- 
bin (30-90 mg/L), troponin-I (0.0-2.0 ng/ml), and troponin-T (0.0-0.1 ng/ml). 
Results. Mean marker values are displayed in the figure below. In all patients studied, all 
markers were elevated above normal by 2 hrs after vessel closure. Mean peak measure- 
